NILO, ANNACARMEN
 Distribuzione geografica
Continente #
NA - Nord America 768
EU - Europa 292
AS - Asia 209
AF - Africa 11
SA - Sud America 4
OC - Oceania 1
Totale 1.285
Nazione #
US - Stati Uniti d'America 767
IT - Italia 184
SG - Singapore 140
DE - Germania 37
CN - Cina 26
FI - Finlandia 21
IE - Irlanda 19
IN - India 16
VN - Vietnam 15
UA - Ucraina 14
TG - Togo 11
TR - Turchia 5
FR - Francia 4
BE - Belgio 3
BR - Brasile 3
CZ - Repubblica Ceca 2
GB - Regno Unito 2
IL - Israele 2
IR - Iran 2
NL - Olanda 2
UZ - Uzbekistan 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
CA - Canada 1
DK - Danimarca 1
LT - Lituania 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
Totale 1.285
Città #
Singapore 127
Chandler 121
Fairfield 66
Boardman 51
Woodbridge 45
Seattle 37
Venezia 36
Udine 29
Wilmington 29
Ashburn 28
Munich 24
Cambridge 20
Ann Arbor 19
Dublin 19
Princeton 19
Tavagnacco 19
Ogden 17
Helsinki 16
Houston 15
Dong Ket 14
Redmond 13
Milan 12
Santa Clara 12
Codroipo 11
Hyderabad 11
Lomé 11
Dearborn 10
Rome 10
Jacksonville 9
Los Angeles 7
Norwalk 7
Trieste 6
Izmir 5
Lappeenranta 5
New York 5
Grand Forks 4
San Diego 4
Bari 3
Bologna 3
Brussels 3
Dallas 3
Glen Rock 3
Halle 3
Reston 3
Rio de Janeiro 3
Wilkes-Barre 3
Zhengzhou 3
Brno 2
Castel San Giovanni 2
Guangzhou 2
Latisana 2
Mumbai 2
Nanjing 2
Palermo 2
Putian 2
Shanghai 2
Tashkent 2
Verona 2
Wuhan 2
Xi'an 2
Agugliano 1
Ardabil 1
Augusta 1
Beijing 1
Buenos Aires 1
Copenhagen 1
Des Moines 1
East Lansing 1
Fayetteville 1
Frankfurt am Main 1
Handan 1
Ho Chi Minh City 1
Kiryat Ono 1
Leawood 1
London 1
Mammelzen 1
Montecatini Terme 1
Nerviano 1
Paris 1
Pasian di Prato 1
Pune 1
Redwood City 1
Riyadh 1
Shenzhen 1
Sydney 1
Tel Aviv 1
Tolentino 1
Toronto 1
Turin 1
Vienna 1
Zanjan 1
Totale 980
Nome #
ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. 136
Timing use of novel anti-epileptic drugs: is earlier better? 98
Investigational therapies for the treatment of narcolepsy 94
Pharmacokinetic and pharmacodynamic considerations for the clinical efficacy of perampanel in focal onset seizures 81
Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features 68
Is the Asymmetric Dimethylarginine (ADMA) the Possible Molecule Driving Endothelial Damage in Young Asymptomatic Patients with Cerebral Small Vessel Disease? 56
Epilepsy with eyelid myoclonias (Jeavons syndrome): an electro-clinical study of 40 patients from childhood to adulthood 56
Epilepsy and episodic ataxia type 2: family study and review of the literature 49
Benign EEG variants in the sleep–wake cycle: A prospective observational study using the 10–20 system and additional electrodes 46
Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up 45
Spikes/spike-waves time-locked to the flash frequency during intermittent light stimulation in Jeavons syndrome 41
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome 38
What’s behind drawing for an artist with left temporal lobe epilepsy? A multimodal neurophysiological study 37
Clinical and magnetic resonance study of a case of subacute sclerosing panencephalitis treated with ketogenic diet 36
Turning off the siren of the night: botulinum toxin for the treatment of nocturnal groaning. A case series 33
A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndrome 31
New-onset status epilepticus in SARS-CoV-2 infection: a case series 31
Reader Response: Prolonged Unconsciousness Following Severe COVID-19 30
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 28
Risk Assessment by Pre-surgical Tractography in Left Hemisphere Low-Grade Gliomas 28
Efficacy of Perampanel in Refractory and Super-Refractory Status Epilepticus with Suspected Inflammatory Etiology: A Case Series 27
Association of Mortality and Risk of Epilepsy With Type of Acute Symptomatic Seizure After Ischemic Stroke and an Updated Prognostic Model 25
Reply letter to "COVID-19 and Recurrent Status Epilepticus" 23
Performing real time neuropsychological testing during awake craniotomy: are dexmedetomidine or propofol the same? A preliminary report 23
Can epilepsy affect normal EEG variants? A comparative study between subjects with and without epilepsy 21
Neurological disorders in COVID-19: a case of Acute Disseminated Encephalomyelitis in an adult patient 20
Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review 20
Effect of Dexmedetomidine versus Propofol on Intraoperative Seizure Onset During Awake Craniotomy: A Retrospective Study 20
A retrospective multicentric study on the effectiveness of intravenous brivaracetam in seizure clusters: Data from the Italian experience 18
Recurrent Status Epilepticus and SARS-CoV-2 infection: the "perfect storm" 18
Post-Stroke Status Epilepticus: Time of Occurrence May Be the Difference? 18
Erenumab Impact on Sleep Assessed With Questionnaires and Home-Polysomnography in Patients With Migraine: The ERESON Study 17
Current and emerging pharmaceutical strategies for the treatment and management of restless legs syndrome 17
Adjunctive Perampanel in Older Patients With Epilepsy: A Multicenter Study of Clinical Practice 16
Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians 16
Intravenous brivaracetam in status epilepticus: A multicentric retrospective study in Italy 14
A real‐world comparison among third‐generation antiseizure medications: Results from the COMPARE study 14
Prognostic factors in epilepsy with eyelid myoclonia (Jeavons syndrome) 13
Meningioma-Related Epilepsy: A Happy Ending? 13
Brivaracetam as add‐on treatment in focal epilepsy: A real‐world time‐based analysis 13
An “epileptic scent”: Olfactory auras in tumor-related epilepsy 13
Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition 12
Ischemic strokes in COVID-19: risk factors, obesity paradox, and distinction between trigger and causal association 12
Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis 7
Implications for driving based on the risk of seizures after ischaemic stroke 6
Pre- and Post-surgical Poor Seizure Control as Hallmark of Malignant Progression in Patients With Glioma? 6
Totale 1.484
Categoria #
all - tutte 9.526
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.526


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020128 0 0 0 0 12 23 32 16 17 20 3 5
2020/2021207 0 5 13 14 4 15 16 11 77 12 9 31
2021/2022190 8 8 55 8 1 2 7 7 1 20 54 19
2022/2023280 20 35 0 32 19 80 4 23 23 7 17 20
2023/2024253 20 16 12 8 14 8 2 38 30 52 8 45
2024/2025319 43 62 126 39 49 0 0 0 0 0 0 0
Totale 1.484